Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

May 2, 2018

284_dirs_2018-05-02_2c70db5e-1013-4375-a0dc-31c079f78c21.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-01

Reporting Person: Watson Ashley (SVP Chief Ethics & Com Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-01 Common Stock M 10441.0000 $0.0000 Acquired 12782.7210 Direct
2018-05-01 Common Stock F 3151.0000 $58.8700 Disposed 9631.7210 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-01 Restricted Stock Unit $ M 10441.0000 Disposed 2018-05-01 Common Stock (10441.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 189.5810 Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through May 1, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.